Mtx Ratiopharm (Methotrexate)

Methotrexate, the active ingredient in Mtx Ratiopharm, is a antimetabolite (folate antagonist) presented as an injectable formulation for epidural, intra‑articular and intramuscular use. It treats rheumatoid arthritis, psoriatic arthritis, certain cancers and ectopic pregnancy in adults.

GNH USA supplies Mtx Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methotrexate is employed across several disease families, primarily targeting inflammatory and proliferative disorders.

Rheumatoid arthritis: reduces joint inflammation and slows disease progression. Psoriatic arthritis: alleviates symptoms and limits joint damage. Certain cancers (e.g., leukemia, lymphoma, solid tumours): inhibits tumour cell proliferation. Ectopic pregnancy: terminates non‑viable pregnancy tissue. Osteoarthritis (intra‑articular injection): provides local anti‑inflammatory effect.

Methotrexate may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea or vomiting. - Oral ulcers or mucositis. - Fatigue or malaise. - Mild elevation of liver enzymes. - Transient bone‑marrow suppression. - Mild skin rash.

Serious or Rare Side Effects: - Severe liver toxicity or fibrosis. - Pulmonary fibrosis or interstitial pneumonitis. - Profound bone‑marrow suppression (pancytopenia). - Acute renal failure. - Life‑threatening infections. - Severe hypersensitivity or anaphylactic reactions.

Methotrexate requires careful monitoring and specific safety measures.

Pregnancy: contraindicated (Category X) – avoid use in pregnant or planning patients. Renal function: assess before initiation and monitor during therapy. Liver function: perform baseline and periodic liver enzyme tests. Hematologic monitoring: regular complete blood counts to detect myelosuppression. Drug interactions: review concomitant medications for potential additive toxicity. Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Methotrexate interacts with several drug classes, necessitating vigilance.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase methotrexate toxicity. - Penicillins (e.g., ampicillin): enhance myelosuppression. - Live vaccines: risk of severe infection. - Trimethoprim‑sulfamethoxazole: potentiate bone‑marrow suppression.

Moderate Interactions (Monitor Closely): - Azathioprine or cyclosporine: additive immunosuppressive effect. - Warfarin: may alter INR, requiring coagulation monitoring. - Oral contraceptives: reduced efficacy, consider alternative contraception. - Proton pump inhibitors: may affect renal clearance.